Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
...o an infant for retinoblastoma at The Vision Center, it is expensive and puts a great strain on the family, especially if they are from another state. our preliminary research shows that once the cup is fitted, the child should be able go home for several weeks. Because the drug is being administered dir...Regular Yoga Practice Is Associated With Mindful Eating
...ociation, confirms their initial hunch. "In our earlier study, we found that middle-age people who...d mindful eating. "These findings fit with our hypothesis that yoga increases mindfulness in eati... At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientis...Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
... the pandemic vaccine. "Filing this application is consistent with our commitment to work collaboratively with public health officials in producin...e to us, while at the same time, continue the important clinical studies of our vaccine." The supplemental application follows recent recommendatio...Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...l performance is a direct result of the success of our technology platform and business strategy. We and our partners are advancing our large and growing pipeline of 19 drugs in developm...Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
...ina is directed by its board-certified radiation oncologists, Dr. John Reilly and Dr. Kolby Sidhu. "HDR brachytherapy is a very effective addition to our fight against cancer. This technique delivers a high dose of radiation directly to the area of disease," according to Dr. Reilly. Dr. Sidhu adds, "C...SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
...tem. "We are excited to have the rollout of the entire OLSAS as per our plan for the India operations," said Dr. Ajit Nair, President, India Operat...d drug safety in an efficient and globally compliant manner, thus providing our clients the best of technology support to run trials more efficiently." ...NewCardio Announces Master Services Agreement With Dedicated Phase I
... excited to add NewCardio's QTinno(TM) solution to our advanced Core ECG laboratory. By integrating this important technological advancement with our existing solutions, we can deliver TQT/QTc studies...money. This is a win-win for Dedicated Phase I and our customers." "This agreement will enable Ded...Labopharm files New Drug Submission with Health Canada for novel antidepressant
...ntidepressant trazodone. "We are pleased to file our New Drug Submission to Health Canada," said James ...pressants represents a significant opportunity for our trazodone formulation and we are currently in disc...ntial partners to support the commercialization of our product in Canada." Labopharm's NDS is based on ...NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
...perations at Novavax, commented, "Demonstration of our ability to construct and produce GMP-quality influ... conditions is an important and successful test of our VLP technology. With further scale up, recombinan...the timeline for vaccine release. We are proud of our staff who worked tirelessly to achieve this import...2,500 Cases Completed With the Magnetic Irrigated Catheter
...xis system, further demonstrating the potential of our remote magnetic navigation technology as a platfor...ing number of community hospitals, which are using our advanced technology to build robust electrophysiol... diverse group of clinicians who now routinely use our Niobe system, we are particularly delighted that t...Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... of 2009, we made a strong commitment to advancing our clinical pipeline," stated Howard W. Robin, Presid... Chief Executive Officer of Nektar. "We completed our Phase 2 clinical program for NKTR-118, and we are ...ngth of Nektar's drug development organization and our successful strategy to focus on developing proprie...DNA Helps Reunite Children With Their Families
...bal biotechnology tools company dedicated to improving the human condition. our systems, consumables and services enable researchers to accelerate scientif...ms Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com. ...ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer
...nt lifetime risk of developing this disease," said Executive Vice President of Corporate Communications Ronald L. Weiss, MD, MBA. "Our goal is to help our clients improve patient care as well as reduce unnecessary expenditures by promoting the benefits of KRAS testing." KRAS mutation-detection...Scientists Discover Origin of Malaria
...ls to humans" Wolfe said. "We now know that malaria, while at least thousands of years old, did not originate in humans but rather was introduced into our species, presumably by the bite of a mosquito that had previously fed on a chimpanzee." Until now, malaria's origin had been unclear. Although ...Project Zero Delay Accelerates Drug's Path to Clinical Trial
...y at AstraZeneca. "AZ is always looking to improve our processes and to optimize value along our pipeline. This achievement is a great example of what can be accomplished when we pair our first class internal capabilities with the strengt...Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...eutic Area Head, Neuroscience, Johnson & Johnson Pharmaceutical Research & Development. "The approval of INVEGA(R) SUSTENNA(TM) demonstrates our commitment to providing valuable novel therapies for schizophrenia. INVEGA(R) SUSTENNA(TM) has a demonstrated safety profile that can help healthcar...Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com . This press release contains ce...for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to con...Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus
...health officers need to know in real-time whether their message is getting out to students. FairChoice Health meets students where they are -- online. our automated notification and tracking service will increase student awareness of the risks of infectious disease and allow school administrators to focu...Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
...uture events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q file...Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture
...he introduction of NutriumMoisture(TM) technology continues that tradition," said K.P. Ananth, Unilever principal research scientist. "We are thrilled our extensive research and testing has allowed us to be the first brand to minimize lipid damage with a liquid cleanser in order to provide intensive mois...Correction to Earlier Release From Jewish Hospital and University of Louisville
...phere-derived cells, which are a mixture of primitive and partially differentiated cells, complicating the recognition of the actual therapeutic cell. our study involves a specific, well-characterized population of undifferentiated cells: the c-kit-positive cardiac stem cells are self-renewing, clonogeni...Cyberonics Provides Update on Depression Post-Approval Study
...p on patients enrolled in the D-21 clinical study. our actual results may differ materially. Important f...nued market acceptance of VNS Therapy and sales of our product; the development and satisfactory completi...potential identification of material weaknesses in our internal controls over financial reporting; risks ...NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
...any, for an ultimate decision on the NDA is not yet known. Dr. Jeffrey Tobias, NeurogesX' Chief Medical Officer commented, "I am grateful to our clinical investigators and the entire NeurogesX team for working together to quickly complete this study. We believe that these results will address t...